Akorn Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurity Failures
Akorn, Inc. is recalling 424,174 bottles of Hydroxyzine Hydrochloride oral solution because the product failed impurities and degradation specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is typically associated with a temporary or medically reversible adverse health consequence. The source text does not report any specific illnesses, injuries, or deaths, and the hazard is a failure of impurities/degradation specifications rather than a high-risk pathogen or structural defect.
Plain-English summary
Akorn, Inc. is recalling 424,174 bottles of Hydroxyzine Hydrochloride oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) bottles. The product is prescription-only and was manufactured for KVK-Tech, Inc. by Hi-Tech Pharmacal Co., Inc.
The recall was initiated because the product failed impurities and degradation specifications. The affected lots include 621637, 621640, 622748, 622751, 623599, 623602, 624132, 624135, 628282, 628285, 628288, 628291, 628850, 628853, 628856, 628859, 629797, 629800, 629803, and 629806, with expiration dates ranging from May 2015 to September 2016.
The product was distributed nationwide, including Puerto Rico. Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) bottle, Rx only, Manufactured for KVK-Tech, Inc., Newtown, PA by Hi-Tech Pharmacal Co., Inc., Amityville, NY, NDC 10702-0052-16
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Oral Solution
- Hazard
- Affected units
- 424,174
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot# 621637
- 621640 Exp 05/2015
- 622748
- 622751 Exp 08/2015
- 623599
- 623602 Exp 09/2015
- 624132
- 624135 Exp 10/2015
- 628282
- 628285
- 628288
- 628291 Exp 06/2016
- 628850
- 628853
- 628856
- 628859 Exp 07/2016
- 629797
- 629800
- 629803
- 629806 Exp 09/2016
Distribution
Part of a larger recall action
This product is one of 2 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08